Analyst Price Targets — GKOS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 20, 2026 11:54 am | — | BTIG | $202.00 | $189.55 | TheFly | Glaukos price target raised to $202 from $193 at BTIG |
| July 30, 2026 4:46 pm | — | H.C. Wainwright | $195.00 | $170.67 | TheFly | Glaukos price target raised to $195 from $168 at H.C. Wainwright |
| July 30, 2026 11:20 am | — | Stifel Nicolaus | $190.00 | $161.66 | TheFly | Glaukos price target raised to $190 from $175 at Stifel |
| July 30, 2026 10:58 am | Matt O'Brien | Piper Sandler | $195.00 | $161.66 | TheFly | Glaukos price target raised to $195 from $165 at Piper Sandler |
| July 30, 2026 10:26 am | Larry Biegelsen | Wells Fargo | $178.00 | $161.66 | TheFly | Glaukos price target raised to $178 from $138 at Wells Fargo |
| July 30, 2026 10:10 am | David Saxon | Needham | $201.00 | $161.66 | StreetInsider | Glaukos Corporation (GKOS) PT Raised to $201 at Needham |
| July 30, 2026 9:05 am | Richard Newitter | Truist Financial | $215.00 | $161.66 | StreetInsider | Glaukos Corporation (GKOS) PT Raised to $215 at Truist Securities |
| July 28, 2026 10:41 am | — | UBS | $150.00 | $151.91 | TheFly | Glaukos assumed with Neutral from Buy at UBS |
| July 16, 2026 2:04 pm | — | Truist Financial | $180.00 | $159.17 | TheFly | Glaukos price target raised to $180 from $160 at Truist |
| July 13, 2026 11:19 am | — | BTIG | $164.00 | $152.72 | TheFly | Glaukos price target raised to $164 from $162 at BTIG |
Latest News for GKOS
Corient Private Wealth LP acquired a new stake in Glaukos Corporation (NYSE: GKOS) during the undefined quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 57,048 shares of the medical instruments supplier's stock, valued at approximately $7,973,000. Corient Private Wealth LP owned approximately 0.10% of Glaukos at the
Glaukos (GKOS) reported earnings 30 days ago. What's next for the stock?
Algert Global LLC lessened its holdings in shares of Glaukos Corporation (NYSE: GKOS) by 43.0% in the second quarter, according to its most recent filing with the SEC. The firm owned 30,871 shares of the medical instruments supplier's stock after selling 23,330 shares during the quarter. Algert Global LLC owned about 0.05% of
Deutsche Bank AG acquired a new stake in Glaukos Corporation (NYSE: GKOS) during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 61,957 shares of the medical instruments supplier's stock, valued at approximately $8,659,000. Deutsche Bank AG owned about 0.11% of Glaukos at the
Glaukos' iDose TR momentum and Epioxa launch are driving record growth, higher 2026 guidance and a broader ophthalmology platform.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for GKOS.
U.S. House Trading
No House trades found for GKOS.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.